NAS10028,958S&P7,624−0.52%GOLD$4,023+0.37%BTC$79,848−1.17%VIX19.45+2.21%live tape · as of 04:14 UTC
The Screen · Technology · Information Technology Services
CAPCapgemini SE
CAP.PA · EURONEXT PARIS · EUR · Market cap $16.2B · 423,405 employees
Capgemini SE, together with its subsidiaries, provides consulting, digital transformation, technology, and engineering services primarily in North America, France, the United Kingdom, Ireland, the rest of Europe, the Asi…
Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price118.00 EUR
Fair value183.12
Ethical score70.0/100
RatingOPPORTUNITY
Our investment reviews on this name
2026-10-11Read Markup105.50+11.8% to today ✓Distribution gives way to Markup first Markup read since August
2026-10-02Read Distribution105.50+11.8% to today Markup gives way to Distribution after a 9% rise in 6 weeks
2026-08-24Read Markup96.72+22.0% to today ✓Distribution gives way to Markup first Markup read since July
2026-07-24Read Distribution96.72+22.0% to today Markup gives way to Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Capgemini SE holds its Markup at $118.00. The statistical read favours the buyers, held for 1 days.
As held on the ledger · 2026-10-14
Phase
Markup
Quantitative state
The statistical read favours the buyers, held for 1 days
Price at the screen
$118.00
Valuation
11.56 trailing · 7.65 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.63
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
32.55%
Below 33%
Interest-bearing debt is just 32.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
9.68%
Below 33%
Cash held in interest-bearing accounts and securities is 9.7% of assets, under the one-third limit.
Pass
Receivables
11.23%
Below 49%
Money owed to the company is 11.2% of assets, under the 49% limit.
Pass
Revenue purity
0.10%
Below 5%
Only 0.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Capgemini SE clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 33%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-25. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CAP.PA's ethical verdict changes
Today CAP.PA passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Conscience Overlay
Conscience flag · AFSC Investigate
The quantitative screen above is arithmetic and this name passes it. Separately, community boycott lists cite this company: Documented on AFSC Investigate. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads OPPORTUNITY: it trades at roughly a 55% discount to our $183.12 fair value, 3.70% revenue growth.
Fair value range in EUR, drawn from the 2026-10-14 screen. The gold marker is the market price at the same screen. A 55.2% margin of safety to the base estimate.
Third-party analyst targets: 18 covering, consensus Buy. The average target sits +24% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-14 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Why it stands out
A 4%-growth business trading at just 7.7x forward earnings. That is a 55% discount to our $183.12 fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 18 analysts rate it Buy with a $146.50 average target, about 24% above the screened price.
The risks · The things to watch: its business and earnings are exposed to France and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CAP.PA trades on EURONEXT PARIS (the company is based in France). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-25Markup$118.00+11.8%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 33%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (18 analysts) rates it buy, with a mean price target of $149.
2026-10-11Markup · changed$105.50+0.0%Entry 7
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 33%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (18 analysts) rates it buy, with a mean price target of $149.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 9.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 33%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (18 analysts) rates it buy, with a mean price target of $149.
2026-08-24Markup · changed$96.72+0.0%Entry 5
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 33%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (18 analysts) rates it buy, with a mean price target of $149.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 33%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (18 analysts) rates it buy, with a mean price target of $149.
2026-07-18Markup$96.72+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 33%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (18 analysts) rates it buy, with a mean price target of $149.
2026-07-03Markup$96.72+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Markup$96.72Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
Period
Price then
Price return
Divs per share
$1,000 became
Total return
1 month
$98.58
+1.0%
$3.40
$1,045
+4.5%
2 months
$97.17
+2.5%
$3.40
$1,060
+6.0%
3 months
$104.15
-4.4%
$3.40
$989
-1.1%
6 months
$147.12
-32.3%
$3.40
$700
-30.0%
1 year
$149.49
-33.4%
$3.40
$689
-31.1%
2 years
$182.82
-45.5%
$6.80
$582
-41.8%
3 years
$156.90
-36.5%
$10.20
$700
-30.0%
5 years
$141.71
-29.7%
$15.85
$815
-18.5%
Historical returns from market close data. Past performance does not guarantee future results.
The Ledger's Promise
This entry now belongs to the ledger. Whatever CAP.PA does next, these words stay.
Capgemini SE · CAP.PA · Markup · $118.00
Recorded 2026-10-14 · before the outcome · scored mechanically